Browse by author
Lookup NU author(s): Professor Vinidh Paleri, Dr Charles Kelly
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2015 JLO (1984) Limited. Primary small cell neuroendocrine carcinoma of larynx is a rare, aggressive type of malignancy. As only about 200 cases worldwide have been reported, any larger institutional experience is valuable. This study reports our experience in managing this rare entity. Methods: Of the nine patients identified, three had metastatic cancer at the time of diagnosis. Four patients underwent radical treatment: one was managed surgically followed by adjuvant chemotherapy and consolidation radiotherapy; the remaining three were treated with neoadjuvant chemotherapy and definitive radiotherapy. Results: Of the 4 patients treated with radical intent, 1 was alive and disease free after 99 months, 2 died of metastatic disease after 22 and 26 months, and 1 was alive after 20 months with a diagnosis of recurrent disease. Conclusion: Our relatively small number of patients confirms other centres' experiences. This cancer has a poorer prognosis than most other head and neck cancers. Although the logistics would be challenging, there is a need for international multicentre trials for this disease modelled on those performed for other cancers, as has been done for paediatric malignancies.
Author(s): Iqbal MS, Paleri V, Moor J, Dobrowsky W, Kelly C, Kovarik J
Publication type: Article
Publication status: Published
Journal: Journal of Laryngology and Otology
Year: 2015
Volume: 129
Issue: 9
Pages: 910-915
Print publication date: 01/09/2015
Online publication date: 15/07/2015
Acceptance date: 13/01/2015
ISSN (print): 0022-2151
ISSN (electronic): 1748-5460
Publisher: Cambridge University Press
URL: https://doi.org/10.1017/S0022215115001668
DOI: 10.1017/S0022215115001668
PubMed id: 26173932
Altmetrics provided by Altmetric
